Global Intracranial Hemorrhage Diagnosis & Treatment Market Research Report—Forecast to 2027
Global Intracranial Hemorrhage Diagnosis & Treatment Market is anticipated to exhibit a CAGR of 5.98% during the review period of 2020 to 2027. Intracranial hemorrhage is a genuine health-related crisis that can be caused because of the development of blood inside the skull. This can prompt an increment in intracranial pressing factor, which can additionally harm cerebrum tissues. The growth of the global market is driven by the rising geriatric population and age-related brain disorders also increase the number of patients in need of diagnostic tools required for assessing the types of hemorrhage. Further, University Hospital, Norway, is determining the effects of antithrombotic drugs for the prevention of ischemic events in patients with recent intracerebral hemorrhage.
The global Intracranial Hemorrhage Diagnosis & Treatment is expected to register a healthy market growth during the review period having the highest market value of USD 1,493.98 Million in 2019. The global market growth is attributed to the rising number of road accidents, and the growing expenditure on healthcare infrastructure. Additionally, an increase in research funding for the treatment of intracranial hemorrhage fuels the growth of the market during the forecast period. However, rising counterfeit drugs & side effects of the treatment, less awareness about the available treatments, and lack of skilled workforce are expected to register the market growth.
Global Intracranial Hemorrhage Diagnosis & Treatment Market has been divided based on Type and Diagnosis & Treatment.
In terms of type segment, the global market has been classified into intracerebral hemorrhage, subarachnoid hemorrhage, epidural hematoma, and subdural hematoma.
In terms of diagnosis & treatment, the intracranial hemorrhage diagnosis & treatment market has been bifurcated into diagnosis and treatment. The diagnosis segment has been further classified into CT, MRI, and others.
The treatment type is further divided into medication and surgery. Based on medication, the market is sub-divided into anti-hypertensive drugs, coagulants, and others. However, the surgery segment further categorizes the market into decompression surgery, craniotomy with open surgery, endoscopic evacuation, stereotactic aspiration, and clipping or coiling procedures.
Geographically, the Global Intracranial Hemorrhage Diagnosis & Treatment Market has been classified into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas is expected to dominate the global intracranial hemorrhage diagnosis & treatment market during the review period owing to the well-developed healthcare sector, increased research spending, rapid adoption of advanced treatment, and the existence of major players in the region. Furthermore, assimilation of clinical data to acknowledge the diagnosis of intracranial hemorrhage and treatment options is expected to propel the research activities in the region.
Europe has expected to register the second largest market of the global Intracranial Hemorrhage Diagnosis & Treatment market followed by the Asia Pacific.
The Key Players in the Global Intracranial Hemorrhage Diagnosis & Treatment Market include Canon Inc. (Japan), FUJIFILM Holdings Corporation (Japan), GE Healthcare (US), Hitachi Ltd. (Japan), Infrascan, inc. (US), Johnson & Johnson (US), Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), Siemens AG (Germany), Stryker Corporation (US) and Others.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.